Previous Page  68 / 74 Next Page
Information
Show Menu
Previous Page 68 / 74 Next Page
Page Background

68

http://www.DGS-PraxisLeitlinien.de

Nr.

Nachweis

87

Napadow V1, Harris RE. What has functional connectivity and chemical neuroimaging in

fibromyalgia taught us about the mechanisms and management of 'centralized' pain?,

Arthritis Res Ther. 2014;16(5):425.

88

Nishishinya, B., et al., Amitriptyline in the treatment of fibromyalgia: a systematic review

of its efficacy. Rheumatology, 2008. 47(12): p. 1741-6.

89

O’Malley, P.G., et al., Treatment of fibromyalgia with antidepressants: a meta-analysis.

Journal of General Internal Medicine, 2000. 15(9): p. 659-66.

90

Orellana, C., et al., Sexual dysfunction in fibromyalgia patients. Clinical & Experimental

Rheumatology, 2008. 26(4): p. 663-6.

91

Orellana, Rodriguez-Andreu, J., et al., Cognitive impairment in patients with fibromyal-

gia syndrome as assessed by the mini-mental state examination.BMC Musculoskeletal

Disorders, 2009. 10: p. 162.

92

Osorio, C.D., et al., Sleep quality in patients with fibromyalgia using the Pittsburgh Sleep

Quality Index. Journal of Rheumatology, 2006. 33(9): p. 1863-5.

93

Pain Pract. 2011 Nov-Dec;11(6):516-27

94

Papapetrou, P.D., Bisphosphonate-associated adverse events. Hormones (Athens), 2009.

8(2): p. 96-110

95

Park, D.C., et al., Cognitive function in fibromyalgia patients. Arthritis & Rheumatism,

2001. 44(9): p. 2125-33.

96

Peng XClin J Pain. Long-term evaluation of opioid treatment in fibromyalgia. 2015

Jan;31(1):7-13

97

Perrot, S., A.H. Dickenson, and R.M. Bennett, Fibromyalgia: harmonizing science with

clinical practice considerations. Pain Practice, 2008.8(3): p. 177-89.

98

Perrot, S., et al., Is there any evidence to support the use of anti-depressants in painful

rheumatological conditions? Systematic review of pharmacological and clinical studies.

Rheumatology, 2008. 47(8): p. 1117-23.

99

Perry, R., R. Terry, and E. Ernst, A systematic review of homoeopathy for the treatment of

fibromyalgia. Clinical Rheumatology, 2010. 29(5): p. 457-64.

100

Pertwee, R.G., Cannabinoid receptors and pain. Prog Neurobiol, 2001. 63(5): p. 569-611.

101

Petzke, F. and D.J. Clauw, Sympathetic nervous system function in fibromyalgia. Curr

Rheumatol Rep, 2000. 2(2): p. 116-23.

102

Pioro-Boisset, M., J.M. Esdaile, and M.A. Fitzcharles, Alternative medicine use in fibromy-

algia syndrome. Arthritis Care and Research, 1996.9(1): p. 13-17.

103

Plesh, O., F. Wolfe, and N. Lane, The relationship between fibromyalgia and temporo-

mandibular disorders: Prevalence and symptom severity.Journal of Rheumatology, 1996.

23(11): p. 1948-1952.

104

Poyhia, R., D. Da Costa, and M.A. Fitzcharles, Previous pain experience in women with

fibromyalgia and inflammatory arthritis and nonpainful controls. Journal of Rheumatolo-

gy, 2001. 28(8): p. 1888-91